GOSS · Company research
Gossamer Bio, Inc. Common Stock (GOSS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Gossamer Bio (GOSS) Stock Sees Fair Value Lift As Analysts Weigh Seralutinib Risks - Yahoo Finance | Gossamer Bio (GOSS) Stock Sees Fair Value Lift As Analysts Weigh Seralutinib Risks Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio(GOSS) Stock Options Chain | Quotes & News - Moomoo | Gossamer Bio(GOSS) Stock Options Chain | Quotes & News Moomoo | View source ↗ | Moomoo | Oct 15, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio Inc. R (4GB0.DU) latest stock news and headlines - Yahoo Finance UK | Gossamer Bio Inc. R (4GB0.DU) latest stock news and headlines Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 14, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio Inc (GOSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey | Gossamer Bio Inc (GOSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey | View source ↗ | TradingKey | Oct 13, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash? - Stocktwits | Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash? Stocktwits | View source ↗ | Stocktwits | Oct 10, 2026 | neutral | 0 | 0.6 |
| Sold shares count toward October meeting voting power at Gossamer Bio (GOSS). - Stock Titan | Sold shares count toward October meeting voting power at Gossamer Bio (GOSS). Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio Inc (GOSS) Stock Price Target & Forecast - TradingKey | Gossamer Bio Inc (GOSS) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Oct 7, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (GOSS) Stock Draws Fresh Price Target Split Before Seralutinib NDA - Yahoo Finance | Gossamer Bio (GOSS) Stock Draws Fresh Price Target Split Before Seralutinib NDA Yahoo Finance | View source ↗ | Yahoo Finance | Oct 1, 2026 | neutral | 0 | 0.6 |
| GOSS News | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMill | GOSS News | GOSSAMER BIO INC (NASDAQ:GOSS) ChartMill | View source ↗ | ChartMill | Sep 26, 2026 | neutral | 0 | 0.6 |
| At Gossamer Bio (GOSS), director Daniel Thomas O's options carry a $10.99 exercise price. - Stock Titan | At Gossamer Bio (GOSS), director Daniel Thomas O's options carry a $10.99 exercise price. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio grants director options on 10,000 shares - Stock Titan | Gossamer Bio grants director options on 10,000 shares Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (NASDAQ: GOSS) links CDO’s 5.8M options to seralutinib FDA timing - Stock Titan | Gossamer Bio (NASDAQ: GOSS) links CDO’s 5.8M options to seralutinib FDA timing Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (GOSS) Stock Sees Fair Value Cut As Analysts Split On Seralutinib - Yahoo Finance | Gossamer Bio (GOSS) Stock Sees Fair Value Cut As Analysts Split On Seralutinib Yahoo Finance | View source ↗ | Yahoo Finance | Aug 16, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (GOSS) Could Be 96% Undervalued After Its Seralutinib NDA Update - Yahoo Finance | Gossamer Bio (GOSS) Could Be 96% Undervalued After Its Seralutinib NDA Update Yahoo Finance | View source ↗ | Yahoo Finance | Jul 31, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes - Yahoo Finance | Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes Yahoo Finance | View source ↗ | Yahoo Finance | Jul 2, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio (GOSS) Stock Faces Mixed Analyst Target Changes On Funding Risk - Yahoo Finance | Gossamer Bio (GOSS) Stock Faces Mixed Analyst Target Changes On Funding Risk Yahoo Finance | View source ↗ | Yahoo Finance | Jun 18, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.